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Abstract The serotonin type 1A (5-HT1A) receptors are
members of a superfamily of seven transmembrane domain
receptors that couple to GTP binding regulatory proteins (G-
proteins). Serotonergic signalling has been shown to play an
important role in alcohol tolerance and dependence. We have
studied the effects of alcohols on ligand (agonist and antagonist)
binding to bovine hippocampal 5-HT1A receptor in native as well
as solubilized membranes. Our results show that alcohols inhibit
the specific binding of the agonist OH-DPAT and the antagonist
p-MPPF to 5-HT1A receptors in a concentration-dependent
manner.
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1. Introduction
Serotonin (5-hydroxytryptamine or 5-HT) is an intrinsically
£uorescent [1], biogenic amine which acts as a neurotransmit-
ter and is found in a wide variety of sites in the central and
peripheral nervous systems [2]. It mediates a variety of phys-
iological responses in distinct cell types. Serotonergic signal-
ling appears to play a key role in the generation and modu-
lation of various cognitive and behavioral functions including
sleep, mood, pain, addiction, locomotion, sexual activity, de-
pression, anxiety, alcohol abuse, aggression and learning [3^
12]. Disruptions in the serotonergic system have been impli-
cated in the etiology of mental disorders such as schizophre-
nia, migraine, depression, suicidal behavior, infantile autism,
eating disorders, and obsessive compulsive disorder [13^16].
Serotonin exerts its diverse actions by binding to distinct
cell-surface receptors which have been classi¢ed into many
groups [17]. Serotonin receptors are members of a superfamily
of seven transmembrane domain receptors [18] that couple to
GTP binding regulatory proteins (G-proteins). Among the
various types of serotonin receptors, the G-protein-coupled
5-HT1A receptor subtype has been the most extensively
studied for a number of reasons [19]. We have recently parti-
ally puri¢ed and solubilized the 5-HT1A receptor from bovine
hippocampus in a functionally active form [20] and have
shown modulation of agonist binding by metal ions and gua-
nine nucleotide [19].
Serotonergic signalling has been shown to play an impor-
tant role in the regulation of alcohol intake, preference and
dependence [10,21^24]. Several groups have found alterations
in serotonin receptor subtypes in di¡erent regions of the ro-
dent brain associated with alcohol tolerance and dependence
[24]. Elevated alcohol consumption has recently been reported
in null mutant mice lacking 5-HT1B receptors [10]. Alcohols
have also been shown to inhibit the 5-HT2A receptor-induced
Ca2-dependent Cl3 currents in Xenopus laevis oocytes [25].
Collectively, these results suggest the involvement of seroto-
nergic neurotransmission in alcohol tolerance and depend-
ence. However, in most of the studies reported so far, the
direct e¡ect of various alcohols on ligand binding properties
of the receptor has not been examined. We report here that
alcohols inhibit the binding of speci¢c agonist and antagonist
to bovine hippocampal 5-HT1A receptor, both in native and in
solubilized membranes.
2. Materials and methods
BCA, CHAPS, EDTA, EGTA, MgCl2, PMSF, Tris, iodoacet-
amide, polyethyleneimine, serotonin, sodium azide, and sucrose were
obtained from Sigma Chemical Co. (St. Louis, MO, USA). [3H]OH-
DPAT (127.0 Ci/mmol) and [3H]p-MPPF (64.6 Ci/mmol) were pur-
chased from DuPont New England Nuclear (Boston, MA, USA). p-
MPPI was from Research Biochemicals International (Natick, MA,
USA) and was a kind gift from Dr. V. Bakthavachalam (National
Institute of Mental Health Chemical Synthesis Program). All other
chemicals used were of the highest available quality. GF/B glass mi-
cro¢ber ¢lters were from Whatman International (Kent, UK). BCA
reagent kit for protein estimation was obtained from Pierce (Rock-
ford, IL, USA). Fresh bovine brains were obtained from a local
slaughterhouse within 10 min of death and the hippocampal region
was carefully dissected out. The hippocampi were immediately £ash
frozen in liquid nitrogen and stored at 370‡C till further use.
Crude membranes were prepared as described earlier by Chattopad-
hyay and Harikumar [20] with some modi¢cations. Bovine hippocam-
pal tissue (V120 g) was homogenized as 10% (w/v) in polytron ho-
mogenizer in bu¡er A (2.5 mM Tris, 0.32 M sucrose, 5 mM EDTA,
5 mM EGTA, 0.02% sodium azide, 0.24 mM PMSF, 10 mM iodo-
acetamide, pH 7.4). The homogenate was centrifuged at 900Ug for
10 min at 4‡C. The supernatant was ¢ltered through four layers of
cheesecloth and the pellet was discarded. The supernatant was further
centrifuged at 50 000Ug for 20 min at 4‡C. The resulting pellet was
suspended in 10 volumes of bu¡er B (50 mM Tris, 1 mM EDTA, 0.24
mM PMSF, 10 mM iodoacetamide, pH 7.4) using a hand-held
Dounce homogenizer and centrifuged at 50 000Ug for 20 min at
4‡C. This procedure was repeated until the supernatant was clear.
The ¢nal pellet (native membrane) was resuspended in a minimum
volume of 50 mM Tris bu¡er (pH 7.4), homogenized using a Dounce
FEBS 21041 2-11-98
0014-5793/98/$19.00 ß 1998 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 8 ) 0 1 2 8 4 - 8
*Corresponding author. Fax: (91) (40) 7171195.
E-mail: amit@ccmb.ap.nic.in
Abbreviations: BCA, bicinchoninic acid; CHAPS, 3-[(3-cholamido-
propyl)-dimethylammonio]-1-propanesulfonate; EDTA, ethylenedi-
aminetetraacetic acid; EGTA, ethylene glycol bis(L-aminoethylether)-
N,N,NP,NP-tetraacetic acid; GABA, Q-aminobutyric acid; 5-HT, 5-
hydroxytryptamine; p-MPPF, 4-(2P-methoxy)-phenyl-1-[2P-(N-2Q-pyr-
idinyl)-p-fluorobenzamido]ethyl-piperazine; p-MPPI, 4-(2P-methoxy)-
phenyl-1-[2P-(N-2Q-pyridinyl)-p-iodobenzamido]ethyl-piperazine; OH-
DPAT, 8-hydroxy-2-(di-N-propylamino)tetralin ; PMSF, phenyl-
methylsulfonyl fluoride; Tris, tris-(hydroxymethyl)aminomethane
FEBS 21041FEBS Letters 438 (1998) 96^100
homogenizer, £ash frozen in liquid nitrogen and stored at 370‡C for
radioligand binding assays or solubilization.
Solubilization of native membranes using CHAPS was carried out
as described previously [20] with some modi¢cations. Crude mem-
branes were incubated with 5 mM CHAPS either in bu¡er C (50
mM Tris, 1 mM EDTA, 10 mM MgCl2, pH 7.4) for agonist binding
studies, or in bu¡er D (50 mM Tris, 1 mM EDTA, pH 7.4) for
binding studies with the antagonist, at a ¢nal protein concentration
of V2 mg/ml for 30 min at 4‡C with occasional shaking. The mem-
branes were brie£y sonicated (5 s) using a Branson model 250 soni¢er,
and mildly homogenized using a Dounce homogenizer (5 times) at the
beginning and the end of the incubation period. After incubation for
30 min, the contents were centrifuged at 100 000Ug for 1 h. The clear
supernatant was carefully removed from the pellet, and used immedi-
ately for binding assays.
Agonist binding assays were performed with varying concentrations
of alcohols as follows. Tubes in triplicate containing 1^1.2 mg of total
protein (for native membrane) or 500 Wl of the CHAPS solubilized
membrane were mixed with the appropriate amounts of any of the
alcohols used (ethanol, 1-butanol, 1-hexanol or 1-octanol) and vor-
texed gently to allow mixing. Higher alcohols could not be used since
they led to insolubility. Bulk (total) alcohol concentrations varied as
follows: ethanol: 0.1^1 M; butanol: 25^500 mM; hexanol: 2^25
mM; octanol: 0.06^8.81 mM. The concentrations of alcohols parti-
tioned into membranes were calculated taking into account the mem-
brane/bu¡er partition coe⁄cients from the literature [26] (see Section
3) and are plotted in the abscissae of the ¢gures. The assay tubes
contained 0.29 nM [3H]OH-DPAT (speci¢c activity 127.0 Ci/mmol)
in a total volume of 1 ml of bu¡er C (50 mM Tris, 1 mM EDTA, 10
mM MgCl2, pH 7.4) and were incubated for 1 h at room temperature.
Control samples were prepared in the same way except that alcohol
was not added to them. Non-speci¢c binding was determined by per-
forming the assay in the presence of 10 WM unlabeled serotonin. The
incubation was terminated by rapid ¢ltration under vacuum in a
Millipore multiport ¢ltration apparatus through Whatman GF/B
(1.0 Wm pore size) 2.5 cm diameter glass micro¢ber ¢lters which
were presoaked in 0.3% polyethyleneimine for 3 h [27]. The ¢lters
were then washed 3 times with 3 ml of ice-cold water, dried, and
the retained radioactivity was measured in a Packard Tri-Carb 1500
scintillation counter using 5 ml of scintillation £uid. Antagonist bind-
ing assays in presence of various alcohols were performed as above
using [3H]p-MPPF (speci¢c activity 64.6 Ci/mmol) as the radioligand.
The assay tubes contained 0.5 nM [3H]p-MPPF in a total volume of
1 ml of bu¡er D. Alcohol was not added to the control samples. Non-
speci¢c binding was determined by performing the assay in the pres-
ence of 10 WM unlabeled p-MPPI. Protein concentration was deter-
mined using BCA reagent [28].
3. Results
Mutagenesis [29,30] and molecular modelling studies [31,32]
have shown that the ligand binding site in serotonin receptors
in general, and in 5-HT1A receptor in particular, is located in
a transmembrane domain. It is therefore important to deter-
mine the actual concentration of alcohols partitioned into
membranes while considering the e¡ect of alcohols on ligand
binding properties of the 5-HT1A receptor. The partitioning of
alcohols from bu¡er into membranes increases with increase
in chain length in a given series [26]. The concentration of
alcohols in membranes were determined as outlined below.
The membrane/bu¡er partition coe⁄cient of an alcohol is
de¢ned as:
P  CM=CB 1
where CM and CB refer to the molar concentrations of the
alcohol in the membrane and bu¡er, respectively. The total
(bulk) concentration of alcohol is given by:
CT  CM  CB 2
Substituting for CB (CB=CT3CM) from Eq. 2 into Eq. 1, we
get:
P  CM=CT3CM 3
Upon rearrangement of Eq. 3, we get:
CM  PCT=1 P 4
Membrane/bu¡er partition coe⁄cients for various alcohols
have been reported by McCreery and Hunt [26]. The mem-
brane concentration of alcohols (CM) can thus be calculated
from the total added concentration (CT) of the alcohol and
the literature value of its membrane/bu¡er partition coe⁄cient
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Table 1
Membrane concentrations of alcohols from total concentrations using membrane/bu¡er partition coe⁄cient
Alcohol Membrane/bu¡er partition coe⁄cienta Total concentration Membrane concentration
(P) (CT, mM) (CM, mM)
Ethanol 0.096 100 8.76
250 21.90
500 43.80
750 65.7
1000 87.6
Butanol 1.52 25 15.08
50 30.16
100 60.32
250 150.79
500 301.59
Hexanol 21.4 2 1.91
4 3.82
6 5.73
8 7.64
10 9.55
25 23.88
Octanol 189 0.06 0.06
0.94 0.93
1.89 1.88
3.77 3.75
6.29 6.26
8.81 8.76
aFrom [26].
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[26]. Table 1 shows the membrane concentrations calculated
this way for various alcohols used in this study. It is apparent
from the table that the di¡erence between the total concen-
tration (CT) and membrane concentration (CM) decreases
from ethanol to octanol because of increased partitioning
into membranes as shown by the increasing value of the par-
tition coe⁄cient (P). The concentrations of alcohols plotted in
Figs. 1 and 2 are actual membrane concentrations calculated
this way and as shown in Table 1.
Among the various types of serotonin receptors, the G-pro-
tein-coupled 5-HT1A receptor subtype has been the most ex-
tensively studied. One of the major reasons for this is the early
availability of a highly selective agonist (OH-DPAT) that al-
lows extensive biochemical, physiological, and pharmacologi-
cal characterization of the receptor [33]. Fig. 1 shows the
inhibition of speci¢c OH-DPAT binding to bovine hippocam-
pal 5-HT1A receptor by various alcohols in a concentration-
dependent manner for native as well as solubilized mem-
branes. The concentration of alcohol plotted here is the actual
concentration of alcohol partitioned into the membrane cal-
culated from Eq. 4. It is interesting to note that although
agonist binding was found to be inhibited in all cases with
increasing alcohol concentration, it was unaltered in case of
ethanol for native membranes. A similar result was reported
in a previous communication [34]. However, Fig. 1 shows a
reduction in agonist binding for ethanol in the case of solu-
bilized membranes, especially toward higher concentrations.
This could be due to a higher water content in solubilized
membranes (in which the lipids are more loosely packed)
which results in increased partitioning of ethanol at a given
total concentration. In general, the inhibition of binding is
more pronounced for longer chain alcohols. Thus, compara-
ble levels of inhibition of binding are achieved at lower mem-
brane concentrations for the longer chain alcohols. The di¡er-
ence in the inhibition patterns for the native and the
solubilized membranes probably re£ects di¡erences in lipid
composition and packing in the two cases.
We had problems performing radioligand binding assays
with the solubilized membrane in the presence of octanol
although assays done with native membrane gave reproduci-
ble results. The reason for this discrepancy is not clear to us.
However, altered partitioning of octanol in the solubilized
membrane could give rise to such artifacts. The packing of
lipids is somewhat loose in the solubilized membrane giving
rise to increased levels of water penetration. This would lead
to an overall increase in membrane polarity which could re-
duce partitioning of octanol in the membrane. This e¡ect may
not be signi¢cant with other alcohols since they are more
polar than octanol.
Although selective 5-HT1A agonists (e.g. OH-DPAT) have
been discovered more than a decade ago [33], the development
of selective 5-HT1A antagonists has been relatively slow and
less successful. Recently, p-MPPI and p-MPPF have been in-
troduced as selective antagonists for the 5-HT1A receptor [35^
38]. These compounds bind speci¢cally to the 5-HT1A receptor
with high a⁄nity. Fig. 2 shows the inhibition of speci¢c p-
MPPF binding to the 5-HT1A receptor by various alcohols for
native and solubilized membranes. In this case also, the in-
hibition of binding is more pronounced for longer chain al-
cohols.
4. Discussion
Both animal and human studies suggest the involvement of
the serotonergic system in ethanol preference and dependence
[10,22]. However, there have been very few studies, at the
molecular level, on the e¡ects of alcohols on ligand binding
properties of the isolated receptors. Our results show that
ligand binding in the 5-HT1A receptor is altered in the pres-
ence of alcohols in a concentration-dependent manner.
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Fig. 1. E¡ect of increasing concentrations of alcohols on the speci¢c
binding of the agonist [3H]OH-DPAT to the 5-HT1A receptor from
bovine hippocampal native (b) and solubilized (R) membranes. Val-
ues are expressed as a percentage of the speci¢c binding obtained in
the absence of any alcohol. The alcohol concentration plotted here
is the actual concentration of alcohol partitioned into the membrane
(see Section 3). See Section 2 for other details.
Fig. 2. E¡ect of increasing concentrations of alcohols on the speci¢c
binding of the antagonist [3H]p-MPPF to the 5-HT1A receptor from
bovine hippocampal native (b) and solubilized (R) membranes. All
other conditions are as in Fig. 1. See Section 2 for other details.
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Interestingly, contrary to the agonist binding results, etha-
nol had considerable inhibitory e¡ects on antagonist (p-
MPPF) binding even in the case of native membranes. This
result, together with the general di¡erence in inhibition pat-
terns for OH-DPAT and p-MPPF binding observed for var-
ious alcohols, may point to overlapping but not identical
binding sites for agonist and antagonist binding. Ethanol
has been reported to bind in the interfacial region of the
membrane, presumably hydrogen bonded to the carbonyl
oxygen of the glycerol backbone [39]. Since the antagonist
e¡ects are signi¢cant in the case of native membranes at low
concentrations of ethanol (see Fig. 2), it is possible that the
antagonist binding pocket is more polar in nature than the
agonist binding site and could even have an interfacial loca-
tion, i.e. at a shallow location in the membrane compared to
the agonist site.
The mechanism of action of alcohols and general anes-
thetics on the central nervous system is generally discussed
in terms of two very di¡erent mechanisms [40]. The ¢rst mech-
anism (the ‘lipid theory’) postulates that alcohols act via some
perturbation of the membrane lipids of the neurons in the
central nervous system. The second mechanism (the ‘protein
theory’) proposes that alcohols act by directly interacting with
a neuronal protein site. Since neurotransmitter-gated ion
channel receptors (such as the nicotinic acetylcholine receptor,
GABAA receptor, the glycine receptor, and the 5-HT3 recep-
tor) are thought to be important targets of alcohol action in
the central nervous system, many of the recent studies directed
at elucidating the mechanism of action of alcohols have dealt
with the e¡ect of alcohols on ligand-gated channels [40]. The
ligand binding site in these receptors lies in the extramembra-
nous domain of the protein [41]. In contrast to this, the ligand
binding sites in the superfamily of G-protein-coupled recep-
tors (such as rhodopsin, L-adrenergic receptor, dopamine re-
ceptors, and serotonin receptors) are formed by their trans-
membrane domains and lie within the membrane bilayer [42].
Di¡erentiating between the two proposed mechanisms (the
‘lipid’ or the ‘protein’ theory) for the action of alcohols is
di⁄cult, especially for members of the superfamily of G-pro-
tein-coupled receptors such as the 5-HT1A receptor, for whom
the ligand binding site is within the membrane. It should be
mentioned here that the action of alcohols on rhodopsin, one
of the best characterized members of this family, has recently
been attributed to lipid-mediated mechanisms [43].
The ligand binding site of the 5-HT1A receptor has stringent
requirements of hydrogen bonding pattern for e⁄cient bind-
ing [31,32]. This would require an optimal local polarity in the
ligand binding pocket. Any agent and/or process that alters
this parameter could induce alterations in binding. Alcohols
are known to change the polarity of membrane interiors by
modulating the hydration level [44,45]. In fact, it has recently
been shown that alcohols can compete with water for the
same hydrogen bonding sites in membranes [46]. This could
explain the altered binding in the presence of alcohols. Alter-
natively, alcohols have also been shown to asymmetrically
a¡ect £uidity of the two lea£ets of the membrane bilayer
[47]. This could perturb the packing of the lipids adjacent
to the membrane embedded receptor (the ‘annular lipids’),
giving rise to altered ligand binding characteristics. In any
event, our results could be signi¢cant in the general context
of the role of serotonergic signalling in alcohol tolerance and
dependence.
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